Brennan v. IQVIA, Inc.

CourtDistrict Court, D. Massachusetts
DecidedMarch 17, 2021
Docket1:20-cv-12230
StatusUnknown

This text of Brennan v. IQVIA, Inc. (Brennan v. IQVIA, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brennan v. IQVIA, Inc., (D. Mass. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

STEPHEN BRENNAN, * * Plaintiff, * * v. * Civil Action No. 20-cv-12230-IT * IQVIA INC. and JON RESNICK, * * Defendants. *

MEMORANDUM AND ORDER March 17, 2021

Plaintiff Stephen Brennan alleges that he was terminated by Defendants IQVIA Inc. and Jon Resnick (collectively “IQVIA”) after performing work that entitled him to a substantial commission and bonus but before being paid for that work. He claims that Defendants’ failure to pay him the earned commission and bonus violated the Massachusetts Wage Act (the “Wage Act”), and that his termination breached the implied covenant of good faith and fair dealing, as recognized in Fortune v. Nat’l Cash Register Co., 373 Mass. 96, 364 N.E.2d 1251, 1257 (1977). Defendants have filed a Motion to Dismiss for Failure to State a Claim [#7], arguing that Plaintiff waived both claims pursuant to a release clause in his severance agreement with IQVIA. For the reasons set forth below, the court concludes that the release does not constitute a waiver under Massachusetts law for Plaintiff’s Wage Act claim. However, the court does find that Plaintiff’s Fortune claim seeking damages for wrongful termination is waived. Accordingly, Defendants’ Motion to Dismiss is GRANTED IN PART and DENIED IN PART. I. FACTUAL BACKGROUND Plaintiff Stephen Brennan started working for Defendant IQVIA on July 16, 2018. Compl. ¶ 8 [#6]. Defendant Jon Resnick is the president of IQVIA. Id. ¶ 3. Brennan’s position at the company was “Senior Director of Business Development” within the Contract Sales and Medical Solutions team. Id. ¶ 9. He earned an annual base salary of $187,775. Id. ¶ 10. In June 2019, Brennan began working on a potential business deal between IQVIA and Supernus Pharmaceuticals (“Supernus”). Id. ¶ 12. At the time Brennan began working with Supernus, Brennan’s team at IQVIA had not previously done business with Supernus. In

November 2019, as a result of Brennan’s investment of significant time and effort, Supernus and IQVIA verbally agreed to move forward on a deal worth nearly $30 million. Id. ¶¶ 13–19, 28. On May 14, 2020, Brennan was notified that he would be “restructured” out of the company and that the termination was not for cause. Id. ¶ 23. Indeed, before his termination, Brennan had not received any written or verbal warnings about his performance at the company. Id. ¶¶ 24–25. At the time of his termination, Brennan entered into a Severance Agreement [#8-1] with IQVIA. The Severance Agreement, which is stylized as part of the “IQVIA Employee Protection Plan,” begins with the explanation that the employee is “being offered payments and benefits as

part of the IQVIA Employee Protection Plan (“Plan”) that [he] would otherwise not have been entitled to receive.” Agreement at 1 [#8-1]. More specifically, the Agreement provided Brennan with $28,888.46 in “severance pay” and a continuance of his health insurance benefits through July 26, 2020. Id. at 4. In return, the Agreement required Brennan to comply with a list of “Employee Obligations” set forth in an appendix. These include requirements that Brennan continue to cooperate in the transition following his termination, that Brennan maintain confidentiality and return any and all IQVIA materials, that Brennan agree to limit any solicitation of IQVIA customers, suppliers, and employees, and that Brennan also agree to limit his competition with IQVIA going forward. Id. at 7–8. In addition, the Agreement included a “Release” that provides: Release. Employee, for Employee, Employee’s family, representatives, successors and assigns, subject to the terms of Paragraph 5 of this Appendix I, releases and forever discharges the Company and its successors, assigns, subsidiaries, affiliates, directors, officers, employees, attorneys, agents and trustees or administrators of any Company plan from any and all claims, demands, debts, damages, injuries, actions or rights of action of any nature whatsoever, whether known or unknown, which Employee had, now has or may have against the Company, its successors, assigns, subsidiaries, affiliates, directors, officers, employees, attorneys, agents and trustees or administrators of any Company plan, from the beginning of Employee’s employment to and including the date of this Agreement, relating to or arising out of Employee’s employment with the Company or the termination of such employment other than a claim with respect to a vested right Employee may have to receive benefits under any plan maintained by the Company. Employee represents that Employee has not filed any action, complaint, charge, grievance or arbitration against the Company or any of its successors, assigns, subsidiaries, affiliates, directors, officers, employees, attorneys, agents and trustees or administrators of any Company plan. If Employee has worked or is working in California, Employee expressly agrees to waive the protection of section 1542 of the California Civil Code because Employee is releasing claims, whether known or unknown. Section 1542 of the California Civil Code states: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him/her must have materially affected his or her settlement with the debtor.” By agreeing to waive the protection of section 1542, Employee expressly acknowledges this Paragraph includes the release of claims which Employee does not know or suspect to exist at the time of this Agreement.

Id. at 5.1 The Agreement also includes a “Covenant Not to Sue,” which provides in whole part: Covenant Not to Sue. Employee covenants that neither Employee, nor any of Employee’s respective heirs, representatives, successors or assigns, subject to the terms of Paragraph 5 of this Appendix I, will commence, prosecute or cause to be commenced or prosecuted against the Company or any of its successors, assigns, subsidiaries, affiliates, directors, officers, employees, attorneys, agents and trustees or administrators of any Company plan, any action or other proceeding based upon any claims, demands, causes of action, obligations, damages or liabilities which are being released by this Agreement, nor will Employee seek to challenge the validity of this Agreement, except that this covenant not to sue does

1 Paragraph 5 of Appendix I of the Agreement excludes from the release filing or participation in certain actions and seeking non-monetary relief with respect to such claims. Id. not affect Employee’s future right to (i) enforce appropriately the terms of this Agreement in a court of competent jurisdiction or (ii) receive compensation related to a whistleblower claim filed with the Securities and Exchange Commission. To the extent Employee receives any monetary relief in connection with any charge, action, investigation or proceeding except as permitted in the previous sentence, the Company will be entitled to offset such amounts against the benefits provided pursuant to this Agreement, to the fullest extent permitted by law.

Id. at 6. Finally, the Agreement included a section where Brennan made certain acknowledgments about the Agreement and what rights he was forfeiting: Employee Review and Acknowledgements; Revocation Period.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Valerie Watterson v. Eileen Page
987 F.2d 1 (First Circuit, 1993)
Haley v. City of Boston
657 F.3d 39 (First Circuit, 2011)
Morales-Cruz v. University of Puerto Rico
676 F.3d 220 (First Circuit, 2012)
Thomas Quesnel v. Prudential Insurance Company
66 F.3d 8 (First Circuit, 1995)
Fortune v. National Cash Register Co.
364 N.E.2d 1251 (Massachusetts Supreme Judicial Court, 1977)
Maddaloni v. Western Mass. Bus Lines, Inc.
438 N.E.2d 351 (Massachusetts Supreme Judicial Court, 1982)
Gram v. Liberty Mutual Insurance
429 N.E.2d 21 (Massachusetts Supreme Judicial Court, 1981)
Maddaloni v. Western Mass. Bus Lines, Inc.
422 N.E.2d 1379 (Massachusetts Appeals Court, 1981)
Sharon v. City of Newton
769 N.E.2d 738 (Massachusetts Supreme Judicial Court, 2002)
Eck v. Godbout
444 Mass. 724 (Massachusetts Supreme Judicial Court, 2005)
Camara v. Attorney General
458 Mass. 756 (Massachusetts Supreme Judicial Court, 2011)
Crocker v. Townsend Oil Co.
464 Mass. 1 (Massachusetts Supreme Judicial Court, 2012)
García-Catalán v. United States
734 F.3d 100 (First Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Brennan v. IQVIA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/brennan-v-iqvia-inc-mad-2021.